Few rewards for innovation

Published: 2012-04-24 06:57:00

Updated: 2012-04-24 06:57:00

The main reason why companies want the pharmaceutical market and the pricing and reimbursement system to be predictable and transparent is that pharma R&D investment is very long-term and carries a significant risk of failure.

“If the market and achievable prices are not predictable and trans...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK